Brain Cancer News and reporting on brain cancer. Nov 11, 2022 Ivy Brain Tumor Center Researcher Wins Grant for Genomic Analysis of Brain Tumors Sep 8, 2022 Ivy Brain Tumor Center Using Novel Liquid Biopsy Technique to Track Brain Tumor Treatment Resistance Jul 12, 2022 NCCN Publishes First Guidelines for Pediatric Brain Cancer, Recommends Broad NGS Profiling Jul 6, 2022 Structural Variant Study Points to Pediatric Glioma Drivers, Prognostic Features Jun 21, 2022 Recursion Launches Clinical Trial for Targeted Drug in NF2-Mutated Meningioma Patients Jun 6, 2022 With ASCO Data, Novartis' Tafinlar-Mekinist Heads Toward FDA for BRAF-Mutant Pediatric Brain Cancer Premium May 17, 2022 Routine Genomic Profiling Could Improve Diagnosis of Aggressive Brain Cancers, Patient Outcomes Premium May 2, 2022 Brain Cancer Canada Funds Development of New Dx Sequencing Assay at St. Michael's Hospital Apr 18, 2022 Black Diamond Therapeutics Doses First Patient in Recurrent EGFR-Mutant Glioblastoma, NSCLC Trial Apr 14, 2022 Mustang Bio to Study CAR T-Cell, Oncolytic Virus Combination for Recurrent Brain Cancer Patients Mar 21, 2022 NIH Launches New Childhood Cancer Genomics Program Mar 9, 2022 Cellevolve Bio, Seattle Children's Therapeutics Ink CAR-T Pact Focused on Pediatric Brain Cancer Feb 23, 2022 National Brain Tumor Society, Yale Cancer Center Researching DNA Damage Response in Brain Cancers Feb 16, 2022 Rozlytrek Studies Show Durable Responses in Patients With Brain Metastases Premium Feb 15, 2022 Lantern Pharma Working With Greehey Children's Cancer Research Institute To ID New Uses for Drugs Dec 16, 2021 Denovo Biopharma IDs Genetic Biomarker to Predict Brain Cancer Gene Therapy Response Aug 16, 2021 FDA Approves Merck's Welireg for Certain Von Hippel-Lindau-Associated Cancers Jun 9, 2021 Prediction Model IDs Brain Cancer Features That Contribute to Survival After CAR T-Cell Therapy May 20, 2021 Mustang Bio Initiates CAR T-Cell Therapy in Phase I Brain Tumor Trial Mar 31, 2021 Biocept Prepares for First FDA Foray With CSF Liquid Biopsy Brain Metastases Assay Premium Load More Breaking News Ratio Therapeutics Raises $20M in Series A Financing Guardant Health, AnHeart Tx to Develop Blood- and Tissue-Based CDx for NSCLC Drug Ellipses Pharma Cleared by FDA to Open Phase I/II AML Trial Survey Reveals Changing Genetic Testing Patterns, Persistent Disparities in Precision Oncology Amgen's Lumakras Sales Increased 58 Percent in Q4 2022 Coeptis Therapeutics, University of Pittsburgh Studying SNAP-CAR Therapy in HER2-Positive Cancers
